Apr 7, 2026 3-5pm ET
Tuesday on The Robert Scott Bell Show:
Hour 1
$2.46 Billion ‘Momnibus’ Bill Targets Pregnant Women for Vaccination—Builds $715 Million Real-Time Surveillance System Activated During Pandemics H.R. 7973, known as the “Momnibus Act,” introduced by Rep. Lauren Underwood (D-IL) on March 18, 2026, with 203 cosponsors, authorizes $2.46 billion to address maternal health disparities while establishing a $715 million real-time federal surveillance and vaccination infrastructure specifically targeting pregnant and postpartum women and their children, with a focus on increasing vaccination rates through demographic-based identification, awareness campaigns, and continuous monitoring that activates during declared public health emergencies or pandemics. The bill directs federal agencies to boost vaccination uptake among pregnant individuals—particularly those from racial/ethnic minority groups or communities with historically lower immunization rates—through equity-focused outreach, provider training, and integration of vaccination data into broader maternal health tracking systems, while allocating substantial funding for expanded CDC maternal mortality and morbidity surveillance, national pregnancy risk monitoring, and NIH emergency research capabilities. A core component is the creation of a nationwide data integration network requiring laboratories and healthcare facilities to collect and transmit detailed demographic information—including race, ethnicity, pregnancy status, gender, primary language, geographic location, and socioeconomic factors—on diagnostic testing, confirmed cases, hospitalizations, and deaths related to infectious diseases, with data centralized at the federal level before de-identification and public reporting on CDC platforms. Within 30 days of an emergency declaration, the HHS Secretary must issue guidance for standardized data collection and reporting, forming what critics describe as a closed-loop system: identify at-risk pregnant populations by demographics, intervene with targeted vaccination and medical services, and continuously track outcomes to refine future responses. Proponents frame the legislation as a necessary response to persistent maternal health disparities and the need for better preparedness against infectious threats during pregnancy, emphasizing improved access to care and data-driven interventions. However, health freedom advocates argue the bill shifts medical decision-making from individual informed consent toward federally coordinated population-level targeting and surveillance, raising concerns about privacy, data centralization, potential coercion through equity campaigns, and the normalization of real-time health monitoring infrastructure that could expand beyond pandemics. The article notes the bill remains in early stages in the House Energy and Commerce Committee with no hearings scheduled yet, and highlights campaign finance ties to healthcare and insurance interests that could benefit from expanded federal vaccination and surveillance programs. It calls on readers to contact Rep. Underwood and cosponsors to oppose what it characterizes as an expansion of centralized control over maternal health decisions and the creation of a permanent pandemic-era tracking apparatus.Special Guest: Dr. Shane Watt
Dr. Watt is a Chiropractor functional health specialist. He is the clinic director of Mountain West Chiropractic, NeuroBolic Health Center, and Utah Wellness Solutions located in South Jordan, Utah. He has been serving our community for over 20 years. He is passionate about his patients and helping them become well.
Welcome back to another “Homeopathic Hits” episode on The Robert Scott Bell Show!
Today’s Homeopathic Hit is Calcarea acetica, Acetate of Lime
He is the clinic director of Mountain West Chiropractic, NeuroBolic Health Center, and Utah Wellness Solutions located in South Jordan, Utah. He has been serving our community for over 20 years. He is passionate about his patients and helping them become well.
Download the Information Sheet
Hour 2
Less Than Half Of Health Care Workers Received An Updated COVID-19 Vaccine: CDC Only 40.2% of U.S. health care personnel received the updated 2024–2025 COVID-19 vaccine during the most recent respiratory virus season, according to a CDC survey published in the Morbidity and Mortality Weekly Report, marking an increase from 31.3% the previous season but remaining well below influenza vaccination rates of 76.3% among the same group and highlighting persistent gaps in uptake among frontline workers despite employer policies and public health recommendations. The online opt-in survey conducted from March 26 to April 17, 2025, collected responses from 2,650 health care workers across various settings and found that COVID-19 vaccination coverage was highest among physicians and assistants/aides (46.7%), those with master’s, professional, or doctoral degrees (47.3%), non-Hispanic Black or African American workers (47.5%), and personnel in long-term care or home health settings (44.5%), while younger workers aged 18–29 showed relatively higher uptake compared to older groups. Influenza vaccination rates remained stable year-over-year but lower than pre-pandemic levels, with strong variation by employer policy: coverage reached 92–98% for influenza and 80–89% for COVID-19 when mandates were in place, versus 42–73% when vaccines were offered on-site without requirements, and as low as 16–49% when neither recommended nor required. The earlier availability of the 2024–2025 COVID-19 vaccine (one month sooner than the prior season) was cited as a contributing factor to the modest increase in uptake, allowing more time for workplace campaigns and access. The CDC researchers noted that workplace strategies such as on-site vaccination, strong recommendations, and requirements remain effective tools for improving coverage and reducing influenza- and COVID-19-related morbidity among health care personnel and the patients they serve. The report acknowledged limitations of self-reported data and the non-probability sampling method while emphasizing the importance of multipronged approaches to boost vaccination. The article presents the findings in the context of broader shifts in federal vaccine guidance, including recent narrowing of recommendations and legal challenges to ACIP changes under the current administration, suggesting that declining or stagnant uptake among health care workers may reflect growing public and professional skepticism, concerns over side effects, and reduced perceived necessity of repeated boosters in an endemic phase of the virus. It underscores ongoing challenges for public health officials in maintaining high coverage among critical workforce groups despite targeted efforts.
The toxic metal in children’s colourful clothes posing hidden health risk Preliminary research presented at the American Chemical Society’s Spring 2026 meeting has found that fabric in some children’s fast-fashion and discount clothing contains lead levels exceeding the U.S. Consumer Product Safety Commission’s 100 parts per million (ppm) safety limit for children’s products, with brightly coloured shirts (particularly red and yellow) showing the highest concentrations due to the use of lead(II) acetate as a low-cost dye fixative to produce vibrant, long-lasting colours. Researchers from Marian University tested 11 shirts in various colours (red, pink, orange, yellow, grey, and blue) purchased from four retailers, including fast-fashion and discount brands, and found that none of the items met federal safety standards; brighter fabrics consistently released more bioaccessible lead than muted tones. In a follow-up experiment simulating children’s mouthing behaviour — such as sucking, chewing, or holding fabric in the mouth — the team estimated that even short periods of exposure could result in lead ingestion exceeding the U.S. Food and Drug Administration’s daily limit for children, raising serious concerns because lead is toxic at any level and young children are especially vulnerable as they frequently put clothing in their mouths. Lead exposure is linked to behavioural problems, damage to the brain and central nervous system, developmental delays, and other adverse health effects, with no safe threshold established. The study authors, including undergraduate researchers Priscila Espinoza and Cristina Avello, noted that while previous research had identified high lead in metal components like zippers, buttons, and snaps, this work highlights contamination directly in the textile fabric itself. They hope future studies will examine more garments, assess the impact of laundering (which may leave lead-containing residue in washing machines), and explore safer plant-based dye fixatives such as those derived from oak bark, pomegranate peel, or rosemary. The findings underscore potential hidden risks in affordable, colourful children’s clothing and call for more thorough pre-market screening, stricter enforcement of lead limits, and greater awareness among parents and regulators about bioaccessible lead in textiles. Although the sample size was small, the consistent exceedance across brands highlights a broader issue in fast fashion production practices that prioritize cost and colour vibrancy over child safety.
SPECIAL FEATURE: Fast Food Medicine Is Exactly That American medicine has evolved into an industrialized “fast food” model that prioritizes volume, standardization, protocol adherence, and revenue generation over individualized, high-quality, patient-centered care, functioning as an emergent property of deeply entrenched financial and regulatory incentives rather than isolated bad actors or conspiracy, according to an in-depth analysis by James Lyons-Weiler, PhD. The article compares modern healthcare to fast-food franchises where consistency and throughput are optimized at the expense of quality and nutrition: physicians function as protocol executors, electronic health records serve as point-of-sale systems, and clinical guidelines act as standardized operating procedures that eliminate beneficial variation in favor of billable, checkbox-driven encounters. A detailed case study illustrates the problem through “Maria,” a 58-year-old woman with mildly elevated blood pressure and ankle swelling who was prescribed amlodipine, which worsened her edema; she was then given hydrochlorothiazide for presumed volume overload, triggering urinary urgency and incontinence, leading to referrals to urology and neurology, five medications, and a misdiagnosis of early cognitive impairment — all while her high-sodium diet and low potassium/magnesium intake went unaddressed because dietary counseling is poorly reimbursed compared to prescriptions and specialist visits. This “prescription cascade” is portrayed as the system working exactly as designed, with no single villain but rather structural incentives that discourage revisiting root causes or non-pharmaceutical solutions. The piece highlights time pressures, citing a 2011 Pediatrics study showing one-third of well-child visits under 10 minutes and declining visit lengths that prevent comprehensive care, alongside a manufactured physician shortage stemming from the 1997 Balanced Budget Act’s residency cap lobbied for by the AMA. It critiques diagnostic inflation (e.g., lowered hypertension thresholds reclassifying millions and expanded “prediabetes” affecting 96 million), financial conflicts in guideline panels (52–69% of members with industry ties), and the unfalsifiable nature of guidelines that shield practitioners from liability while marginalizing effective non-drug interventions like magnesium supplementation or lifestyle changes that are non-billable. Specialty-specific examples include persistent use of stents and arthroscopies despite trials showing limited benefit over medical management or placebo, high cesarean rates driven by incentives, and psychiatry’s preference for quick medication checks over therapy. The article contrasts this with promising alternatives like Direct Primary Care (DPC) models that enable longer visits and reduce cascades through membership fees, and calls for a major NIH-funded research agenda focused on comparative effectiveness, pharmacogenomics, long-term drug safety, nutrition vs. drugs head-to-head trials, and therapies like hyperbaric oxygen, arguing that the MAHA initiative offers an opportunity to shift from industry-aligned basic science toward honest, patient-centered evidence. Lyons-Weiler concludes that society gets the medicine it pays for and that ending the “fast food era” requires reforming incentives, restoring clinical judgment, and prioritizing rigorous, independent research to determine what truly works for individual patients rather than perpetuating a profit-optimized system that delivers diminished care.
Why Are Our Children Developing High Blood Pressure — And How Do We Stop It? High blood pressure (hypertension), once considered an adult condition, is now affecting children and adolescents at alarming rates, with prevalence nearly doubling over the past 20 years from approximately 3.4% in 2000 to 6.5% in 2020, impacting over 114 million young people worldwide, while the 2017 American Academy of Pediatrics guideline update — which aligned adolescent blood pressure thresholds more closely with adult cut-points (≥120/80 mm Hg for elevated BP and ≥130/80 mm Hg for hypertension) and recalculated percentiles using only normal-weight children — further increased diagnosed cases, raising adolescent hypertension from 8.4% to 12.9% and overall high blood pressure from 14.5% to 26.7%. Obesity stands as the strongest predictor, with obese children six times more likely to have elevated blood pressure than normal-weight peers and rates reaching 30–42% in some groups, compounded by physical inactivity (failing to meet 60 minutes of daily moderate-to-vigorous activity or exceeding two hours of sedentary screen time), diets high in sodium, ultra-processed foods, and sugary drinks while low in fruits, vegetables, fiber, and potassium, poor sleep quality often linked to overweight, and less common medical causes such as kidney disease, congenital heart issues, endocrine disorders, or chronic stress. These factors contribute to early structural heart changes, including left ventricular hypertrophy in a significant portion of affected children, raising lifelong risks of adult hypertension, heart attack, stroke, kidney disease, and subtle cognitive effects, with obese youth already showing increased urinary albumin, retinal vessel narrowing, and early atherosclerosis. The article argues that the rise reflects both genuine lifestyle-driven metabolic dysfunction and lowered diagnostic thresholds that medicalize more children, warning against defaulting to pharmaceutical management in developing bodies and instead prioritizing root-cause prevention through sustainable family-based changes. Recommended solutions include gradual weight management if needed, at least 60 minutes of daily physical activity (sports, walking, cycling), limiting screen time to under two hours, stress reduction via mindfulness, breathwork, nature time, and emotional processing, adopting a nutrient-dense diet rich in fruits, vegetables, healthy fats, and protein while avoiding ultra-processed items, fast food, and excess sodium, ensuring age-appropriate sleep in a dark environment, and fostering family routines with shared meals and joyful movement. Supplements such as magnesium, omega-3s, CoQ10, resveratrol, and quercetin may offer supportive benefits, though FDA rules restrict companies from sharing such evidence-based information as it could be deemed an illegal “disease claim.” The piece critiques the normalization of medicating children for preventable lifestyle conditions and calls for greater emphasis on natural, preventive approaches to reverse the trend before it burdens another generation with lifelong cardiovascular risk.Question of The Day!
Robert mentioned a 4th Saturday monthly meetup of some kind for members of some kind – What is this? Where / How do learn more? If interested, how do I join? Robert, I met u in St Paul, MN for a Health Freedom Congress. Whew, that was pre-Covid long ago.
Maria




